Streamlining of Procedure for Written Confirmation (WC) Applications via CDSCO SUGAM Portal

Notification / Circular No.: File No.: I C-21011/41/2026-eoffice/34688 dated March 27, 2026

Applicable Act / Rule: Drugs and Cosmetics Act, 1940

In the existing process, applications for Written Confirmation (WC) for Active Pharmaceutical Ingredients exported to the European Union were processed through CDSCO via the SUGAM portal with multiple levels of review. These applications are required to comply with Article 46(2)(b) of Directive 2001/83/EC for exports to the EU. The procedure involved both zonal/sub-zonal offices and CDSCO Headquarters, leading to longer processing timelines. To streamline and ensure time-bound disposal, the procedure has now been simplified by reducing duplication in the review process.

  1. Upon receipt of applications on the SUGAM portal, the Zonal/Sub-zonal offices of CDSCO shall verify the appropriateness of documents submitted by the applicant and upload the Inspection Report (IR), Compliance Verification Report (CVR), and recommendation letter, and forward the application to Headquarters within three (03) weeks of receipt.
  2. The International Cell, CDSCO Headquarters shall review the adequacy of documents and dispose of the application within three (03) weeks of receipt, and queries shall be issued by Headquarters based on inputs from Zonal/Sub-zonal offices.
  3. The revised procedure eliminates the double layer of review to simplify the process and ensure faster processing timelines.

Disclaimer: The information contained in this Article is intended solely for personal non-commercial use of the user who accepts full responsibility of its use. The information in the article is general in nature and should not be considered to be legal, tax, accounting, consulting or any other professional advice. We make no representation or warranty of any kind, express or implied regarding the accuracy, adequacy, reliability or completeness of any information on our page/article. 

To stay updated Subscribe to our newsletter today

Explore other Legal updates on the 1-Comply and follow us on LinkedIn to stay updated 

Post Views: 4

Schedule A Demo